Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A family nurse practitioner (FNP) has recently obtained prescriptive
authority in a state requiring collaborative practice with a physician.
Before prescribing a Schedule II stimulant for an adult with newly
diagnosed attention-deficit/hyperactivity disorder (ADHD), which action
is the most appropriate?
A. Prescribe the medication because all APRNs have unrestricted
federal authority to prescribe controlled substances.
B. Verify that state law, collaborative practice requirements, DEA
registration, and employer policies authorize the prescription.
C. Obtain approval from the patient's insurance company before issuing
the prescription.
D. Delegate prescribing authority to the clinic pharmacist.
Correct Answer: B
Rationale: APRNs must practice within the limits of federal law, state
nurse practice acts, DEA regulations (when applicable), collaborative
agreements, and institutional policies. Prescriptive authority varies
among states. Insurance approval is unrelated to legal authority,
pharmacists cannot receive delegated prescribing authority from an
APRN, and prescriptive authority is not universally unrestricted across
all states.
Question 2
,A newly certified AGPCNP is evaluating a patient with uncomplicated
hypertension. Which factor should have the greatest influence on
selecting the initial antihypertensive medication?
A. The pharmaceutical representative's recommendation
B. The patient's comorbidities, contraindications, and evidence-based
treatment guidelines
C. The medication with the longest package insert
D. The medication the clinician has prescribed most frequently
Correct Answer: B
Rationale: Evidence-based prescribing requires individualized
medication selection based on the patient's diagnoses, comorbidities,
contraindications, risk factors, and current clinical guidelines.
Pharmaceutical marketing and clinician preference should never
supersede evidence-based decision-making.
Question 3
A PMHNP prescribes sertraline for major depressive disorder. Which
counseling statement best reflects appropriate prescribing practice?
A. "Stop taking the medication as soon as you feel better."
B. "If you miss one dose, double the next dose."
C. "It may take several weeks before you experience full therapeutic
benefit, so continue taking the medication as prescribed."
D. "You should discontinue treatment if nausea occurs during the first
week."
Correct Answer: C
, Rationale: SSRIs often require several weeks before maximal
therapeutic effects occur. Patients should be counseled regarding
adherence, expected onset, adverse effects, and follow-up. Abrupt
discontinuation and dose doubling are inappropriate and may increase
adverse outcomes.
Question 4
An APRN reviews a patient's medication list before prescribing a new
drug. What is the primary purpose of performing medication
reconciliation?
A. Reduce the number of available treatment options
B. Identify potential drug interactions, therapeutic duplication,
allergies, and medication errors
C. Determine insurance eligibility
D. Reduce documentation requirements
Correct Answer: B
Rationale: Medication reconciliation is a core patient safety activity
that identifies current medications, allergies, duplications, omissions,
and potential interactions before initiating or modifying therapy. It
helps prevent medication-related harm.
Question 5
An adult patient requests an antibiotic for symptoms consistent with a
viral upper respiratory infection. What is the best prescribing response?